Prostate Specific Antigen (PSA) Testing Market - Forecast(2019 - 2024)

Report Code: HCR 0038 Report Format: PDF + Excel Database
Prostate Specific Antigen (PSA) Testing Market Overview:
The global prostate-specific antigen testing market is primarily progressing growth because of the rise in prostate cancer among men, who are over 50 years in age. Furthermore, the adoption of various assay based methods and various new inventions for the diagnosis of prostate cancer has raised the demand for PSA testing. The combination of advanced technology for PSA testing has improved the accuracy and specificity of the results playing an important role in boosting the market. Europe contributes for a huge revenue market share for prostate specific antigen testing, accounting for nearly 45% of the global revenue. The market for prostate specific antigen testing in 2017 was $ 2264.84 million and is expected to reach $ 2774.12 million by 2023 at an estimated CAGR of 4.14% during forecast period of 2018-2023

Prostate Specific Antigen (PSA) Testing Market Outlook:
Prostate-specific antigen (PSA) is a type of glycoprotein secreted by epithelial prostatic cells. There are two forms of PSA that circulates freely through the body, either bound to other cells or on their own. The higher levels of the PSA indicate a higher chances of being affected by Prostate cancer. The PSA levels are measured by conducting tests such as Total prostate Specific Antigen Test (tPSA), Free Prostate Specific Antigen Test (fPSA), Complex Prostate Specific Antigen Test (cPSA), Prostate Specific Antigen Reverse Transcription Polymerase chain reaction test (PSA-RT PCR) and so on. In addition to these tests there are some assays for identification of the PSA levels such as Radioimmunoassay (RIA), Enzyme Immunoassay (EIA), PCA3Test, Trans-rectal Ultrasound, Biopsy and other tests. Further tests for Density of PSA and Velocity of PSA were identified, but had no such significance and acceptance. 

Prostate specific Antigen Testing Market report comprises of pricing analysis for different types of PSA tests conducted segmented geographically. Europe accounted for price of $47.5 for PSA testing in 2017 and estimated to be $46.16 by 2022. Europe region has the highest prices for PSA Testing in 2017 and is also estimated to have the same in 2022 as well.

Prostate Specific Antigen (PSA) Testing Market Growth drivers:
Prostate specific antigen testing market is driving ahead because of the increase in geriatric population.   Also, the increased public awareness about the benefits of the Prostate cancer screening, Technological advancements in testing and treating the Prostate cancer, Several Reimbursement policies   for the prostate cancer treatments in various developed and developing regions are affecting the growth of Prostate specific antigen market. According to U.S. Census Bureau’s 2017 National Population Projections.     By 2030, all baby boomers will be older than 65 so that 1 in every 5 residents will be in his or her retirement age. This indicates the growth in the size of geriatric population.

Prostate Specific Antigen (PSA) Testing Market Challenges:
Prostate specific antigen testing market need to face some hard situations because of the False-positive or False-negative results of PSA test. Also most of these tests like PSA Screening had a lot of side effects such as difficulties in flow of urine, effects on functioning of bowel, erectile dysfunction and frequent pains along with the false results, thereby hindering the growth of Prostate specific antigen testing market. Higher improvements in the technology resulting in most simplified and accurate results in the tests like Prostate Health Index (phi) can reduce the growth in PSA testing market unless there is a change in the way the tests are treated.



Prostate Specific Antigen (PSA) Testing Market Research Scope:
The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Prostate specific antigen testing market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, product and pricing analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of PSA tests in the Prostate specific antigen testing market, and their complete details including their forecast.

Prostate Specific Antigen (PSA) Testing Market Report: Industry Coverage

Prostate Specific Antigen Testing Market – By Tests type:  Total Prostate Specific Antigen Test (tPSA), Complex Prostate Specific Antigen Test (cPSA), Free Prostate Specific Antigen Test (fPSA), Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test (PSA RT-PCR), PCA3Test, Trans-rectal Ultrasound, Biopsy.

Prostate Specific Antigen Testing Market – By Assays type: Radioimmunoassay (RIA), Enzyme Immunoassay (EIA).

The Prostate specific antigen testing market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:
  • North America: The U.S., Canada, Mexico
  • South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
  • Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
  • APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
  • Middle East and Africa: Israel, South Africa, Saudi Arabia

Prostate Specific Antigen (PSA) Testing Market Key Players Perspective:  
Some of the Key players in this market that have been studied for this report include:
Abbott Laboratories, Inc., Bayer AG., Beckman Coulter, Inc., GE Healthcare, GlaxoSmithKline, plc., Novartis Pharma AG., UroLogix, Inc., Bristol - Myers Squibb Company, AstraZeneca plc. and so on.

Market Research and Market Trends of Prostate Specific Antigen (PSA) Testing Market
  • A new test named Gallium-68 PSMA PET Scan has been came into light for locating the recurrence of prostate cancer in the patients. This scan evaluates the prostate cancer recurrence with PSA level of less than 2 ng/dl (Nanogram per Decilitre). This imaging helps in reducing the clinical risk after certain Radical procedures and biopsies. 
  • Diagnostic performance for prostate cancer is highly depended on the measurement of PSA ratio in clinical serum in the zone between 4.0 to 10.0 ng/Ml. Simultaneous detection of dual prostate specific antigens using Surface-Enhanced Raman Scattering-Based Immunoassay helps in diagnosing the prostate cancer more accurately. 
  • Prostate specific antigen testing is good in sensitivity but low in specificity resulting in false results and further biopsies which are not even required. After certain research identification of new reliable assay to measure Glypican-1 in plasma and serum using biomarkers has been taken place to improve detection of prostate cancer. Being a novel prostate cancer biomarker, its impact on improvement of treatments would be higher than before. 
  • A new assay named PSA Glycomics Assay reveals multiple glycoforms of PSA in urinary extract, including sialic acid linkage isomers as well the level of (core-)fucosylation. As per Cure for Cancer Foundation, Astellas Pharma B.V., the European Union and SCIEX. , Using this high performance PGA, evaluation of PSA glycosylation is possible for early detetion of Prostate Cancers.  
1. Prostate Specific Antigen Testing Market - Overview
1.1. Definitions and Scope
2. Prostate Specific Antigen Testing Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Prostate Specific Antigen Testing Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Prostate Specific Antigen Testing Market– Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Prostate Specific Antigen Testing Market– Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Prostate Specific Antigen Testing Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Prostate Specific Antigen Testing Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
8. Prostate Specific Antigen Testing Market– By Test type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Service Revenue and Trends by type of test
8.3. Service Segment Analysis   by test type
8.3.1. Preliminary tests
8.3.1.1. Total Prostate Specific Antigen Test
8.3.1.2. Complex Prostate Specific Antigen Test
8.3.1.3. Free Prostate Specific Antigen Test
8.3.1.4. Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test
8.3.2. Confirmatory tests
8.3.2.1. PCA3Test
8.3.2.2. Trans-rectal Ultrasound
8.3.2.3. Biopsy
9. Prostate Specific Antigen Testing Market– By Assays type (Market Size -$Million / $Billion)
9.1. Radioimmunoassay (RIA)
9.2. Enzyme Immunoassay (EIA)
10. Prostate Specific Antigen Testing Market- By Geography (Market Size -$Million / $Billion)
10.1. Prostate Specific Antigen Testing Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Prostate Specific Antigen Testing Market- South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Prostate Specific Antigen Testing Market- Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Prostate Specific Antigen Testing Market– APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
10.8.5.8. Hong Kong  
10.8.5.9. Rest of APAC
10.9. Prostate Specific Antigen Testing Market– Middle East Segment and Africa Segment Research
10.10. Middle East & Africa Market Research (Market Size -$Million / $Billion)
10.10.1. Segment type Size and Market Size Analysis 
10.10.2. Revenue and Trend Analysis
10.10.3. Application Revenue and Trends by type of Application 
10.10.4. Company Revenue and Product Analysis
10.10.5. Middle East Segment Product type and Application Market Size
10.10.5.1. Israel 
10.10.5.2. Saudi Arabia
10.10.5.3. UAE
10.10.6. Africa Segment Analysis
10.10.6.1. South Africa
10.10.6.2. Rest of Middle East & Africa
11. Prostate Specific Antigen Testing Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Prostate Specific Antigen Testing Market – Industry / Segment Competition landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practices for companies
13. Prostate Specific Antigen Testing Market – Key Company List by Country Premium
14. Prostate Specific Antigen Testing Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. Abbott Laboratories Inc.
14.3. Bayer AG.
14.4. Beckman Coulter Inc.
14.5. GE Healthcare
14.6. GlaxoSmithKline plc.
14.7. Novartis Pharma AG.
14.8. UroLogix Inc.
14.9. Bristol - Myers Squibb Company
14.10. AstraZeneca plc. 
14.11. Company 10
14.12. Company 11
14.13. Company 12 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Prostate Specific Antigen Testing Market -Appendix
15.1. Abbreviations
15.2. Sources
16. Prostate Specific Antigen Testing Market -Methodology Premium
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends
List of Tables:
Table 1: Prostate Specific Antigen (PSA) Testing Market Overview 2019-2024
Table 2: Prostate Specific Antigen (PSA) Testing Market Leader Analysis 2018-2019 (US$)
Table 3: Prostate Specific Antigen (PSA) Testing Market Product Analysis 2018-2019 (US$)
Table 4: Prostate Specific Antigen (PSA) Testing Market End User Analysis 2018-2019 (US$)
Table 5: Prostate Specific Antigen (PSA) Testing Market Patent Analysis 2013-2018* (US$)
Table 6: Prostate Specific Antigen (PSA) Testing Market Financial Analysis 2018-2019 (US$)
Table 7: Prostate Specific Antigen (PSA) Testing Market Driver Analysis 2018-2019 (US$)
Table 8: Prostate Specific Antigen (PSA) Testing Market Challenges Analysis 2018-2019 (US$)
Table 9: Prostate Specific Antigen (PSA) Testing Market Constraint Analysis 2018-2019 (US$)
Table 10: Prostate Specific Antigen (PSA) Testing Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Prostate Specific Antigen (PSA) Testing Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Prostate Specific Antigen (PSA) Testing Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Prostate Specific Antigen (PSA) Testing Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Prostate Specific Antigen (PSA) Testing Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Prostate Specific Antigen (PSA) Testing Market Value Chain Analysis 2018-2019 (US$)
Table 16: Prostate Specific Antigen (PSA) Testing Market Pricing Analysis 2019-2024 (US$)
Table 17: Prostate Specific Antigen (PSA) Testing Market Opportunities Analysis 2019-2024 (US$)
Table 18: Prostate Specific Antigen (PSA) Testing Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Prostate Specific Antigen (PSA) Testing Market Supplier Analysis 2018-2019 (US$)
Table 20: Prostate Specific Antigen (PSA) Testing Market Distributor Analysis 2018-2019 (US$)
Table 21: Prostate Specific Antigen (PSA) Testing Market Trend Analysis 2018-2019 (US$)
Table 22: Prostate Specific Antigen (PSA) Testing Market Size 2018 (US$)
Table 23: Prostate Specific Antigen (PSA) Testing Market Forecast Analysis 2019-2024 (US$)
Table 24: Prostate Specific Antigen (PSA) Testing Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2019-2024 ($)
Table 26: Prostate Specific Antigen (PSA) Testing Market By Test, Revenue & Volume, By Free Prostate Specific Antigen Test, 2019-2024 ($)
Table 27: Prostate Specific Antigen (PSA) Testing Market By Test, Revenue & Volume, By Complex Prostate Specific Antigen Test, 2019-2024 ($)
Table 28: Prostate Specific Antigen (PSA) Testing Market By Test, Revenue & Volume, By Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test, 2019-2024 ($)
Table 29: Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2019-2024 ($)
Table 30: Prostate Specific Antigen (PSA) Testing Market By Assays, Revenue & Volume, By Radioimmunoassay (RIA), 2019-2024 ($)
Table 31: Prostate Specific Antigen (PSA) Testing Market By Assays, Revenue & Volume, By Enzyme Immunoassays (EIA), 2019-2024 ($)
Table 32: North America Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2019-2024 ($)
Table 33: North America Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2019-2024 ($)
Table 34: South america Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2019-2024 ($)
Table 35: South america Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2019-2024 ($)
Table 36: Europe Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2019-2024 ($)
Table 37: Europe Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2019-2024 ($)
Table 38: APAC Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2019-2024 ($)
Table 39: APAC Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2019-2024 ($)
Table 40: Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2019-2024 ($)
Table 41: Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2019-2024 ($)
Table 42: Russia Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2019-2024 ($)
Table 43: Russia Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2019-2024 ($)
Table 44: Israel Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2019-2024 ($)
Table 45: Israel Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2019-2024 ($)
Table 46: Top Companies 2018 (US$) Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume
Table 47: Product Launch 2018-2019 Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume
Table 48: Mergers & Acquistions 2018-2019 Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume

List of Figures:

Figure 1: Overview of Prostate Specific Antigen (PSA) Testing Market 2019-2024
Figure 2: Market Share Analysis for Prostate Specific Antigen (PSA) Testing Market 2018 (US$)
Figure 3: Product Comparison in Prostate Specific Antigen (PSA) Testing Market 2018-2019 (US$)
Figure 4: End User Profile for Prostate Specific Antigen (PSA) Testing Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Prostate Specific Antigen (PSA) Testing Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Prostate Specific Antigen (PSA) Testing Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Prostate Specific Antigen (PSA) Testing Market 2018-2019
Figure 8: Ecosystem Analysis in Prostate Specific Antigen (PSA) Testing Market 2018
Figure 9: Average Selling Price in Prostate Specific Antigen (PSA) Testing Market 2019-2024
Figure 10: Top Opportunites in Prostate Specific Antigen (PSA) Testing Market 2018-2019
Figure 11: Market Life Cycle Analysis in Prostate Specific Antigen (PSA) Testing Market
Figure 12: GlobalBy Test Prostate Specific Antigen (PSA) Testing Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy Assays Prostate Specific Antigen (PSA) Testing Market Revenue, 2019-2024 ($)
Figure 14: Global Prostate Specific Antigen (PSA) Testing Market - By Geography
Figure 15: Global Prostate Specific Antigen (PSA) Testing Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 16: Global Prostate Specific Antigen (PSA) Testing Market CAGR, By Geography, 2019-2024 (%)
Figure 17: North America Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 18: US Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 60: U.K Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 93: China Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($) Prostate Specific Antigen (PSA) Testing Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122: Russia Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2019-2024 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%) Prostate Specific Antigen (PSA) Testing Market 
Figure 131: Developments, 2018-2019* Prostate Specific Antigen (PSA) Testing Market 
Figure 132: Company 1 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2018 (%)